Next Article in Journal
(N,N′-Di-tert-butyl-S-phenylsulfinimidamidato-κNN′)-chlorogermanium-κGe-chloro(η2,η2-cycloocta-1,5-diene)rhodium
Previous Article in Journal
5-Fluorouracil/Coumarin and 5-Fluorouracil/Chromone Hybrids: Synthesis and Drug-Likeness Modeling
 
 
Short Note
Peer-Review Record

1,4-Bis(2-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethyl)piperazine

Molbank 2024, 2024(1), M1780; https://doi.org/10.3390/M1780
by Nikolai S. Li-Zhulanov *, Artem D. Rogachev, Yuri V. Gatilov, Konstantin P. Volcho and Nariman F. Salakhutdinov
Reviewer 1: Anonymous
Reviewer 2:
Molbank 2024, 2024(1), M1780; https://doi.org/10.3390/M1780
Submission received: 15 January 2024 / Revised: 7 February 2024 / Accepted: 12 February 2024 / Published: 28 February 2024

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

N. S. Li-Zhulanov and his group represented the structure of the title compound, which include the synthetic method.

 In the introduction, they explained the aim of synthesizing the title compound in detail, based on their previous research results. This emphasized the importance of the title compound. Moreover, the synthetic procedure is fine, and the structural analysis and the spectrum data are also well organized to show the product.

Overall, I think the manuscript would be acceptable and is enough for publication on Molbank. Short comments are below.

1.        In the 1H NMR spectrum data, the number of hydrogen atoms is different from that of the compound in lines 99-101 on page 4.

2.        1H-NMR and/or 13C-NMR should be deleted hyphens in lines 99 and 102 on page 4.

Author Response

We greatly appreciate the comments by the reviewer.

1)    In the 1H NMR spectrum data, the number of hydrogen atoms is different from that of the compound in lines 99-101 on page 4.

Response: We carefully checked the data and corrected the number of hydrogen atoms.

 

2)    1H-NMR and/or 13C-NMR should be deleted hyphens in lines 99 and 102 on page 4.

Response: Corrected. There is the updated spectrum data:

1H NMR (CDCl3, 600 MHz): δ 5.20 (br.s, 2H, H-2), 2.64–2.28 (m, 8H, piperazine), 2.37–2.29 (m, 6H, H-7’, H-11), 2.25–2.10 (m, 8H, H-3, H-10), 2.02–2.06 (m, 2H, H-4), 2.00 (t, J=5.6 Hz, 2H, H-6), 1.24 (s, 6H, CH3-8), 1.11 (d, J=8.5 Hz, 2H, H-7), 0.79 (s, 6H CH3-9). 13C NMR (CDCl3, 150 MHz): δ 146.3 (C-1), 116.9 (C-2), 56.7 (C-11), 53.1 (piperazine), 45.9 (C-6), 40.7 (C-4), 37.9 (C-5), 34.3 (C-10), 31.6 (C-7), 31.2 (C-3), 26.2 (C-8), 21.1 (C-9).

Reviewer 2 Report

Comments and Suggestions for Authors

The manuscript describes the synthesis of the piperazine derivative, 2, which might have pharmaceutical interest. The results are clearly presented and the experimental part rigorously performed and commented. I recommend its publication in the present form.

Author Response

We are deeply grateful for the high appreciation of our work.

Back to TopTop